Overview
- 45 inspections across 42 sites are on record.
- 24 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-07-02.
At a glance
Inspections
45
Sites
42
Observations
24
Career since
May 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Serum Institute of India Private Ltd. | 2 Jul 2024 | Biologics | On file |
| Boehringer Ingelheim RCV GmbH & CO KG | 5 Dec 2023 | Biologics | On file |
| NOVAVAX CZ a.s | 18 Jul 2023 | Biologics | On file |
| Kamada - Production Plant | 2 Mar 2023 | Biologics | On file |
| Serum Institute of India Private Ltd. | 19 Apr 2022 | Biologics | On file |
Sites inspected
Serum Institute of India Private Ltd.Pune, India2 insp.
Boehringer Ingelheim RCV GmbH & CO KGVienna, Austria1 insp.
NOVAVAX CZ a.sJevany, Czech Republic1 insp.
Kamada - Production PlantMP Negev, Israel1 insp.
Co-investigators
Investigators who share inspections with this person.
Mural B Gavini9 shared
Anissa M Cheung5 shared
Prajakta A Varadkar3 shared
Obinna R Echeozo2 shared
Linda Thai2 shared
Donald B Ertel1 shared
Latorie S Jones1 shared
Olga Simakova1 shared
Viviana Matta1 shared
Prabhu P Raju1 shared
Full investigator report
Get the verbatim findings behind Pankaj H Amin's 24 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site